STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
Mertiva AB (STO:DIAM-B)(Pink Sheets:DMYDY):
This has been communicated in a previous press release, but the company wants to make the market aware of this again to avoid any misunderstandings.
About Mertiva
Mertiva AB (former Diamyd Medical) primarily consists of holdings in liquid assets and holdings in Protein Sciences Corporation and Mercodia AB.
Mertiva (former Diamyd Medical) shares are listed on Nasdaq OMX (segment Small Cap) in Stockholm (ticker: DIAM B) and on OTCQX in the US (ticker: DMYDY) administered by the Pink OTC Markets and the Bank of New York Mellon (PAL).
More information can be found at www.mertiva.se
This information is disclosed in accordance with the Swedish Securities Markets Act, the Swedish Financial Instruments Trading Act, or the requirements stated in the listing agreements.
Mertiva AB (publ) Karlavägen 108, SE-115 26 Stockholm, Sweden. E-mail: info@mertiva.com. Reg. no: 556530-1420
This information was brought to you by Cision http://news.cision.com